Loading…
Personality disorders and depression
Background. Personality disorders (PDs) were assessed among depressed out-patients by clinical interview before and after antidepressant treatment with fluoxetine to assess the degree of stability of PD diagnoses and determine whether changes in PD diagnoses across treatment are related to the degre...
Saved in:
Published in: | Psychological medicine 2002-08, Vol.32 (6), p.1049-1057 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c467t-d0206581d80ba1ed504e93e8c827251f6fcc02f056403591955cfa8baf4cceae3 |
---|---|
cites | |
container_end_page | 1057 |
container_issue | 6 |
container_start_page | 1049 |
container_title | Psychological medicine |
container_volume | 32 |
creator | FAVA, M. FARABAUGH, A. H. SICKINGER, A. H. WRIGHT, E. ALPERT, J. E. SONAWALLA, S. NIERENBERG, A. A. WORTHINGTON III, J. J. |
description | Background. Personality disorders (PDs) were assessed among depressed out-patients by clinical interview before and after antidepressant treatment with fluoxetine to assess the degree of stability of PD diagnoses and determine whether changes in PD diagnoses across treatment are related to the degree of improvement in depressive symptoms. Method. Three hundred and eighty-four out-patients (55% women; mean age = 39.9±10.5) with major depressive disorder (MDD) diagnosed with the SCID-P were enrolled into an 8 week trial of open treatment with fluoxetine 20 mg/day. The SCID-II was administered to diagnose PDs at baseline and endpoint. Results. A significant proportion (64%) of our depressed out-patients met criteria for at least one co-morbid personality disorder. Following 8 weeks of fluoxetine treatment, there was a significant reduction in the proportion of patients meeting criteria for avoidant, dependent, passive-aggressive, paranoid and narcissistic PDs. From baseline to endpoint, there was also a significant reduction in the mean number of criteria met for paranoid, schizotypal, narcissistic, borderline, avoidant, dependent, obsessive–compulsive, passive aggressive and self-defeating personality disorders. While changes in cluster diagnoses were not significantly related to improvement in depressive symptoms, there were significant relationships between degree of reduction in depressive symptoms (percentage change in HAM-D-17 scores) and degree of change in the number of criteria met for paranoid, narcissistic, borderline and dependent personality disorders. Conclusions. Personality disorder diagnoses were found to be common among untreated out-patients with major depressive disorder. A significant proportion of these patients no longer met criteria for personality disorders following antidepressant treatment, and changes in personality disorder traits were significantly related to degree of improvement in depressive symptoms in some but not all personality disorders. These findings suggest that the lack of stability of PD diagnoses among patients with current MDD may be attributable in part to a direct effect of antidepressant treatment on behaviours and attitudes that comprise PDs. |
doi_str_mv | 10.1017/S0033291702005780 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72064263</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0033291702005780</cupid><sourcerecordid>72064263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-d0206581d80ba1ed504e93e8c827251f6fcc02f056403591955cfa8baf4cceae3</originalsourceid><addsrcrecordid>eNqFkF9LG0EUxYdSaWLsB-iLhGL7tnrv_N9HCRqrARX1eZjMzJaNm904k4B--07I0oBS-jQw53cP5xxCviGcIqA6ewBgjJaogAIIpeETGSKXZaFLpT-T4VYutvqAHKa0AECGnH4hA6QUudJySE7uQkxda5t6_Tb2deqizx9j2_qxD6sYUqq79ogcVLZJ4Wv_jsjT5cXj5KqY3U5_Tc5nheNSrQufY0ih0WuYWwxeAA8lC9ppqqjASlbOAa1ASA5MlFgK4Sqr57bizgUb2Ij83PmuYveyCWltlnVyoWlsG7pNMir7cyrZf0GhuFYq1x2R7-_ARbeJuW4yFLhABEEzhDvIxS6lGCqzivXSxjeDYLZDmw9D55vj3ngzXwa_v-iXzcCPHrDJ2aaKtnV12nNMc1qWW67YcXVah9e_uo3PRiqmhJHTe0MvJ7Ob--uZmWae9WHtch5r_zvsK_077h_KdqEG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204511052</pqid></control><display><type>article</type><title>Personality disorders and depression</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Social Science Premium Collection</source><source>Sociology Collection</source><source>Cambridge University Press</source><creator>FAVA, M. ; FARABAUGH, A. H. ; SICKINGER, A. H. ; WRIGHT, E. ; ALPERT, J. E. ; SONAWALLA, S. ; NIERENBERG, A. A. ; WORTHINGTON III, J. J.</creator><creatorcontrib>FAVA, M. ; FARABAUGH, A. H. ; SICKINGER, A. H. ; WRIGHT, E. ; ALPERT, J. E. ; SONAWALLA, S. ; NIERENBERG, A. A. ; WORTHINGTON III, J. J.</creatorcontrib><description>Background. Personality disorders (PDs) were assessed among depressed out-patients by clinical interview before and after antidepressant treatment with fluoxetine to assess the degree of stability of PD diagnoses and determine whether changes in PD diagnoses across treatment are related to the degree of improvement in depressive symptoms. Method. Three hundred and eighty-four out-patients (55% women; mean age = 39.9±10.5) with major depressive disorder (MDD) diagnosed with the SCID-P were enrolled into an 8 week trial of open treatment with fluoxetine 20 mg/day. The SCID-II was administered to diagnose PDs at baseline and endpoint. Results. A significant proportion (64%) of our depressed out-patients met criteria for at least one co-morbid personality disorder. Following 8 weeks of fluoxetine treatment, there was a significant reduction in the proportion of patients meeting criteria for avoidant, dependent, passive-aggressive, paranoid and narcissistic PDs. From baseline to endpoint, there was also a significant reduction in the mean number of criteria met for paranoid, schizotypal, narcissistic, borderline, avoidant, dependent, obsessive–compulsive, passive aggressive and self-defeating personality disorders. While changes in cluster diagnoses were not significantly related to improvement in depressive symptoms, there were significant relationships between degree of reduction in depressive symptoms (percentage change in HAM-D-17 scores) and degree of change in the number of criteria met for paranoid, narcissistic, borderline and dependent personality disorders. Conclusions. Personality disorder diagnoses were found to be common among untreated out-patients with major depressive disorder. A significant proportion of these patients no longer met criteria for personality disorders following antidepressant treatment, and changes in personality disorder traits were significantly related to degree of improvement in depressive symptoms in some but not all personality disorders. These findings suggest that the lack of stability of PD diagnoses among patients with current MDD may be attributable in part to a direct effect of antidepressant treatment on behaviours and attitudes that comprise PDs.</description><identifier>ISSN: 0033-2917</identifier><identifier>EISSN: 1469-8978</identifier><identifier>DOI: 10.1017/S0033291702005780</identifier><identifier>PMID: 12214786</identifier><identifier>CODEN: PSMDCO</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Adolescent ; Adult ; Aged ; Antidepressant drugs ; Antidepressive Agents - therapeutic use ; Biological and medical sciences ; Cluster Analysis ; Comorbidity ; Depression ; Depression - diagnosis ; Depression - drug therapy ; Depression - epidemiology ; Female ; Fluoxetine - therapeutic use ; Humans ; Male ; Medical sciences ; Middle Aged ; Neuropharmacology ; Patients ; Personality disorders ; Personality Disorders - diagnosis ; Personality Disorders - drug therapy ; Personality Disorders - epidemiology ; Personality Inventory - statistics & numerical data ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychometrics ; Psychopharmacology ; Treatment ; Treatment Outcome ; USA</subject><ispartof>Psychological medicine, 2002-08, Vol.32 (6), p.1049-1057</ispartof><rights>2002 Cambridge University Press</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-d0206581d80ba1ed504e93e8c827251f6fcc02f056403591955cfa8baf4cceae3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/204511052/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/204511052?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,778,782,12829,21377,21378,27907,27908,30982,30983,33594,33595,34513,34514,43716,44098,72711,73972,74390</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13842996$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12214786$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FAVA, M.</creatorcontrib><creatorcontrib>FARABAUGH, A. H.</creatorcontrib><creatorcontrib>SICKINGER, A. H.</creatorcontrib><creatorcontrib>WRIGHT, E.</creatorcontrib><creatorcontrib>ALPERT, J. E.</creatorcontrib><creatorcontrib>SONAWALLA, S.</creatorcontrib><creatorcontrib>NIERENBERG, A. A.</creatorcontrib><creatorcontrib>WORTHINGTON III, J. J.</creatorcontrib><title>Personality disorders and depression</title><title>Psychological medicine</title><addtitle>Psychol. Med</addtitle><description>Background. Personality disorders (PDs) were assessed among depressed out-patients by clinical interview before and after antidepressant treatment with fluoxetine to assess the degree of stability of PD diagnoses and determine whether changes in PD diagnoses across treatment are related to the degree of improvement in depressive symptoms. Method. Three hundred and eighty-four out-patients (55% women; mean age = 39.9±10.5) with major depressive disorder (MDD) diagnosed with the SCID-P were enrolled into an 8 week trial of open treatment with fluoxetine 20 mg/day. The SCID-II was administered to diagnose PDs at baseline and endpoint. Results. A significant proportion (64%) of our depressed out-patients met criteria for at least one co-morbid personality disorder. Following 8 weeks of fluoxetine treatment, there was a significant reduction in the proportion of patients meeting criteria for avoidant, dependent, passive-aggressive, paranoid and narcissistic PDs. From baseline to endpoint, there was also a significant reduction in the mean number of criteria met for paranoid, schizotypal, narcissistic, borderline, avoidant, dependent, obsessive–compulsive, passive aggressive and self-defeating personality disorders. While changes in cluster diagnoses were not significantly related to improvement in depressive symptoms, there were significant relationships between degree of reduction in depressive symptoms (percentage change in HAM-D-17 scores) and degree of change in the number of criteria met for paranoid, narcissistic, borderline and dependent personality disorders. Conclusions. Personality disorder diagnoses were found to be common among untreated out-patients with major depressive disorder. A significant proportion of these patients no longer met criteria for personality disorders following antidepressant treatment, and changes in personality disorder traits were significantly related to degree of improvement in depressive symptoms in some but not all personality disorders. These findings suggest that the lack of stability of PD diagnoses among patients with current MDD may be attributable in part to a direct effect of antidepressant treatment on behaviours and attitudes that comprise PDs.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antidepressant drugs</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cluster Analysis</subject><subject>Comorbidity</subject><subject>Depression</subject><subject>Depression - diagnosis</subject><subject>Depression - drug therapy</subject><subject>Depression - epidemiology</subject><subject>Female</subject><subject>Fluoxetine - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neuropharmacology</subject><subject>Patients</subject><subject>Personality disorders</subject><subject>Personality Disorders - diagnosis</subject><subject>Personality Disorders - drug therapy</subject><subject>Personality Disorders - epidemiology</subject><subject>Personality Inventory - statistics & numerical data</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychometrics</subject><subject>Psychopharmacology</subject><subject>Treatment</subject><subject>Treatment Outcome</subject><subject>USA</subject><issn>0033-2917</issn><issn>1469-8978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>ALSLI</sourceid><sourceid>HEHIP</sourceid><sourceid>M2S</sourceid><recordid>eNqFkF9LG0EUxYdSaWLsB-iLhGL7tnrv_N9HCRqrARX1eZjMzJaNm904k4B--07I0oBS-jQw53cP5xxCviGcIqA6ewBgjJaogAIIpeETGSKXZaFLpT-T4VYutvqAHKa0AECGnH4hA6QUudJySE7uQkxda5t6_Tb2deqizx9j2_qxD6sYUqq79ogcVLZJ4Wv_jsjT5cXj5KqY3U5_Tc5nheNSrQufY0ih0WuYWwxeAA8lC9ppqqjASlbOAa1ASA5MlFgK4Sqr57bizgUb2Ij83PmuYveyCWltlnVyoWlsG7pNMir7cyrZf0GhuFYq1x2R7-_ARbeJuW4yFLhABEEzhDvIxS6lGCqzivXSxjeDYLZDmw9D55vj3ngzXwa_v-iXzcCPHrDJ2aaKtnV12nNMc1qWW67YcXVah9e_uo3PRiqmhJHTe0MvJ7Ob--uZmWae9WHtch5r_zvsK_077h_KdqEG</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>FAVA, M.</creator><creator>FARABAUGH, A. H.</creator><creator>SICKINGER, A. H.</creator><creator>WRIGHT, E.</creator><creator>ALPERT, J. E.</creator><creator>SONAWALLA, S.</creator><creator>NIERENBERG, A. A.</creator><creator>WORTHINGTON III, J. J.</creator><general>Cambridge University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20020801</creationdate><title>Personality disorders and depression</title><author>FAVA, M. ; FARABAUGH, A. H. ; SICKINGER, A. H. ; WRIGHT, E. ; ALPERT, J. E. ; SONAWALLA, S. ; NIERENBERG, A. A. ; WORTHINGTON III, J. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-d0206581d80ba1ed504e93e8c827251f6fcc02f056403591955cfa8baf4cceae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antidepressant drugs</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cluster Analysis</topic><topic>Comorbidity</topic><topic>Depression</topic><topic>Depression - diagnosis</topic><topic>Depression - drug therapy</topic><topic>Depression - epidemiology</topic><topic>Female</topic><topic>Fluoxetine - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neuropharmacology</topic><topic>Patients</topic><topic>Personality disorders</topic><topic>Personality Disorders - diagnosis</topic><topic>Personality Disorders - drug therapy</topic><topic>Personality Disorders - epidemiology</topic><topic>Personality Inventory - statistics & numerical data</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychometrics</topic><topic>Psychopharmacology</topic><topic>Treatment</topic><topic>Treatment Outcome</topic><topic>USA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FAVA, M.</creatorcontrib><creatorcontrib>FARABAUGH, A. H.</creatorcontrib><creatorcontrib>SICKINGER, A. H.</creatorcontrib><creatorcontrib>WRIGHT, E.</creatorcontrib><creatorcontrib>ALPERT, J. E.</creatorcontrib><creatorcontrib>SONAWALLA, S.</creatorcontrib><creatorcontrib>NIERENBERG, A. A.</creatorcontrib><creatorcontrib>WORTHINGTON III, J. J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection【Remote access available】</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Psychology Database</collection><collection>ProQuest Research Library</collection><collection>Sociology Database (ProQuest)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychological medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FAVA, M.</au><au>FARABAUGH, A. H.</au><au>SICKINGER, A. H.</au><au>WRIGHT, E.</au><au>ALPERT, J. E.</au><au>SONAWALLA, S.</au><au>NIERENBERG, A. A.</au><au>WORTHINGTON III, J. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Personality disorders and depression</atitle><jtitle>Psychological medicine</jtitle><addtitle>Psychol. Med</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>32</volume><issue>6</issue><spage>1049</spage><epage>1057</epage><pages>1049-1057</pages><issn>0033-2917</issn><eissn>1469-8978</eissn><coden>PSMDCO</coden><abstract>Background. Personality disorders (PDs) were assessed among depressed out-patients by clinical interview before and after antidepressant treatment with fluoxetine to assess the degree of stability of PD diagnoses and determine whether changes in PD diagnoses across treatment are related to the degree of improvement in depressive symptoms. Method. Three hundred and eighty-four out-patients (55% women; mean age = 39.9±10.5) with major depressive disorder (MDD) diagnosed with the SCID-P were enrolled into an 8 week trial of open treatment with fluoxetine 20 mg/day. The SCID-II was administered to diagnose PDs at baseline and endpoint. Results. A significant proportion (64%) of our depressed out-patients met criteria for at least one co-morbid personality disorder. Following 8 weeks of fluoxetine treatment, there was a significant reduction in the proportion of patients meeting criteria for avoidant, dependent, passive-aggressive, paranoid and narcissistic PDs. From baseline to endpoint, there was also a significant reduction in the mean number of criteria met for paranoid, schizotypal, narcissistic, borderline, avoidant, dependent, obsessive–compulsive, passive aggressive and self-defeating personality disorders. While changes in cluster diagnoses were not significantly related to improvement in depressive symptoms, there were significant relationships between degree of reduction in depressive symptoms (percentage change in HAM-D-17 scores) and degree of change in the number of criteria met for paranoid, narcissistic, borderline and dependent personality disorders. Conclusions. Personality disorder diagnoses were found to be common among untreated out-patients with major depressive disorder. A significant proportion of these patients no longer met criteria for personality disorders following antidepressant treatment, and changes in personality disorder traits were significantly related to degree of improvement in depressive symptoms in some but not all personality disorders. These findings suggest that the lack of stability of PD diagnoses among patients with current MDD may be attributable in part to a direct effect of antidepressant treatment on behaviours and attitudes that comprise PDs.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>12214786</pmid><doi>10.1017/S0033291702005780</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-2917 |
ispartof | Psychological medicine, 2002-08, Vol.32 (6), p.1049-1057 |
issn | 0033-2917 1469-8978 |
language | eng |
recordid | cdi_proquest_miscellaneous_72064263 |
source | Applied Social Sciences Index & Abstracts (ASSIA); Social Science Premium Collection; Sociology Collection; Cambridge University Press |
subjects | Adolescent Adult Aged Antidepressant drugs Antidepressive Agents - therapeutic use Biological and medical sciences Cluster Analysis Comorbidity Depression Depression - diagnosis Depression - drug therapy Depression - epidemiology Female Fluoxetine - therapeutic use Humans Male Medical sciences Middle Aged Neuropharmacology Patients Personality disorders Personality Disorders - diagnosis Personality Disorders - drug therapy Personality Disorders - epidemiology Personality Inventory - statistics & numerical data Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychometrics Psychopharmacology Treatment Treatment Outcome USA |
title | Personality disorders and depression |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T02%3A26%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Personality%20disorders%20and%20depression&rft.jtitle=Psychological%20medicine&rft.au=FAVA,%20M.&rft.date=2002-08-01&rft.volume=32&rft.issue=6&rft.spage=1049&rft.epage=1057&rft.pages=1049-1057&rft.issn=0033-2917&rft.eissn=1469-8978&rft.coden=PSMDCO&rft_id=info:doi/10.1017/S0033291702005780&rft_dat=%3Cproquest_cross%3E72064263%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c467t-d0206581d80ba1ed504e93e8c827251f6fcc02f056403591955cfa8baf4cceae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=204511052&rft_id=info:pmid/12214786&rft_cupid=10_1017_S0033291702005780&rfr_iscdi=true |